Patent 6902922 was granted and assigned to Novozymes A/S on June, 2005 by the United States Patent and Trademark Office.
New subtilisin homologues (both nucleic acids and proteins) are provided. Compositions which include these new proteins, recombinant cells, shuffling methods involving the new homologues, antibodies to the new homologues, and methods of using the homologues are also provided.